Halbert Hargrove Global Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-316
Closed -$11K 94
2019
Q3
$11K Buy
+316
New +$11.5K ﹤0.01% 86

Other funds holding PFE

Halbert Hargrove Global Advisors's PFE Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Pfizer (PFE) in Q2 2026: 17 shares worth $420. The stake represents ﹤0.01% of the portfolio and ranks #558 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in PFE as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.06M in Q4 2021. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Halbert Hargrove Global Advisors held 17 shares of Pfizer worth $420 as of Q2 2026.
  • Pfizer was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • Pfizer made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #558 holding.
  • Halbert Hargrove Global Advisors first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
  • Halbert Hargrove Global Advisors's Pfizer position peaked at $1.06M in Q4 2021.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.